Loss of XIAP sensitizes colon cancer cells to PPARγ independent antitumor effects of troglitazone and 15-PGJ2

Cancer Letters

Volumn 268, Issue 2, 2008, Pages 260-271

  Qiao, Liang ^a   Dai, Yun ^a,b   Gu, Qing ^a,b   Chan, Kwok Wah ^a   Ma, Juan ^a   Lan, H Y ^a   Zou, Bing ^a   Rocken, Christoph ^c   Ebert, Matthias P A ^d   Wong, Benjamin C Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Colon cancer; Ligands; PPAR ; Therapy; XIAP

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2 CHLORO 5 NITROBENZANILIDE; CASPASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; TROGLITAZONE; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN HCT116; COLON CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; ENZYME DEGRADATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SENSITIZATION; UPREGULATION; XENOGRAFT;

ANILIDES; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CASPASES; CHROMANS; COLONIC NEOPLASMS; DOWN-REGULATION; HCT116 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED BALB C; PPAR GAMMA; PROSTAGLANDIN D2; THIAZOLIDINEDIONES; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

MUS;

EID: 48549105519     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.04.003     Document Type: Article

References (43)

1. Ambrosini G., Adida C., and Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3 (1997) 917-921
2. Shiraki K., Sugimoto K., Yamanaka Y., Yamaguchi Y., Saitou Y., Ito K., Yamamoto N., Yamanaka T., Fujikawa K., Murata K., and Nakano T. Overexpression of X-linked inhibitor of apoptosis in human hepatocellular carcinoma. Int. J. Mol. Med. 12 (2003) 705-708
3. Inoue H., Shiraki K., Murata K., Sugimoto K., Kawakita T., Yamaguchi Y., Saitou Y., Enokimura N., Yamamoto N., Yamanaka Y., and Nakano T. Adenoviral-mediated transfer of p53 gene enhances TRAIL-induced apoptosis in human hepatocellular carcinoma cells. Int. J. Mol. Med. 14 (2004) 271-275
4. Marienfeld C., Yamagiwa Y., Ueno Y., Chiasson V., Brooks L., Meng F., and Patel T. Translational regulation of XIAP expression and cell survival during hypoxia in human cholangiocarcinoma. Gastroenterology 127 (2004) 1787-1797
5. Holcik M., Gibson H., and Korneluk R.G. XIAP: apoptotic brake and promising therapeutic target. Apoptosis 6 (2001) 253-261
6. Fulda S., and Debatin K.M. Targeting inhibitor of apoptosis proteins (IAPs) for diagnosis and treatment of human diseases. Recent Patents Anticancer Drug Discov. 1 (2006) 81-89
7. Hafner C., Reichle A., and Vogt T. New indications for established drugs: combined tumor-stroma-targeted cancer therapy with PPARγ agonists, COX-2 inhibitors, mTOR antagonists and metronomic chemotherapy. Curr. Cancer Drug Targets 5 (2005) 393-419
8. Spiegelman B. PPARγ: adipogenic regulator and thiazolidinedione receptor. Diabetes 47 (1998) 507-514
9. Wang T., Xu J., Yu X., Yang R., and Han Z.C. Peroxisome proliferator-activated receptor γ in malignant diseases. Crit. Rev. Oncol. Hematol. 58 (2006) 1-14
10. Terashita Y., Sasaki H., Haruki N., Nishiwaki T., Ishiguro H., Shibata Y., Kudo J., Konishi S., Kato J., Koyama H., Kimura M., Sato A., Shinoda N., Kuwabara Y., and Fujii Y. Decreased peroxisome proliferator-activated receptor γ gene expression is correlated with poor prognosis in patients with esophageal cancer. Jpn. J. Clin. Oncol. 32 (2002) 238-243
11. Yu J., Qiao L., Zimmermann L., Ebert M.P., Zhang H., Lin W., Röcken C., Malfertheiner P., and Farrell G.C. Peroxisome proliferator-activated receptor γ activation inhibits tumor progression in hepatocellular carcinoma in vitro and in vivo. Hepatology 43 (2006) 134-143
12. Sarraf P., Mueller E., Jones D., King F.J., DeAngelo D.J., Partridge J.B., Holden S.A., Chen L.B., Singer S., Fletcher C., and Spiegelman B.M. Differentiation and reversal of malignant changes in colon cancer through PPAR γ. Nat. Med. 4 (1998) 046-1052
13. Brockman J.A., Gupta R.A., and Dubois R.N. Activation of PPAR γ leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology 115 (1998) 1049-1055
14. Kitamura S., Miyazaki Y., Shinomura Y., Kondo S., Kanayama S., and Matsuzawa Y. Peroxisome proliferator-activated receptor γ induces growth arrest and differentiation markers of human colon cancer cells. Jpn. J. Cancer Res. 90 (1999) 75-80
15. Shimada T., Kojima K., Yoshiura K., Hiraishi H., and Terano A. Characteristics of the peroxisome proliferator activated receptor g (PPARγ) ligand induced apoptosis in colon cancer cells. Gut 50 (2002) 658-664
16. Chen G.G., Lee J.F., Wang S.H., Chan U.P., Ip P.C., and Lau W.Y. Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and NF-κB in human colon cancer. Life Sci. 70 (2002) 2631-2646
17. Yoshizumi T., Ohta T., Ninomiya I., Terada I., Fushida S., Fujimura T., Nishimura G., Shimizu K., Yi S., and Miwa K. Thiazolidinedione, a peroxisome proliferator-activated receptor-γ ligand, inhibits growth and metastasis of HT-29 human colon cancer cells through differentiation-promoting effects. Int. J. Oncol. 25 (2004) 631-639
18. Sasaki T., Fujii K., Yoshida K., Shimura H., Sasahira T., Ohmori H., and Kuniyasu H. Peritoneal metastasis inhibition by linoleic acid with activation of PPARγ in human gastrointestinal cancer cells. Virchows Arch. 448 (2006) 422-427
19. Kuniyasu H., Yoshida K., Sasaki T., Sasahira T., Fujii K., and Ohmori H. Conjugated linoleic acid inhibits peritoneal metastasis in human gastrointestinal cancer cells. Int. J. Cancer 118 (2006) 571-576
20. Panigrahy D., Singer S., Shen L.Q., Butterfield C.E., Freedman D.A., Chen E.J., Moses M.A., Kilroy S., Duensing S., Fletcher C., Fletcher J.A., Hlatky L., Hahnfeldt P., Folkman J., and Kaipainen A. PPAR γ ligands inhibit primary tumour growth and metastasis by inhibiting angiogenesis. J. Clin. Invest. 110 (2002) 923-932
21. Lefebvre A.M., Chen I., Desreumaux P., Najib J., Fruchart J.C., Geboes K., Briggs M., Heyman R., and Auwerx J. Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat. Med. 4 (1998) 1053-1057
22. Saez E., Tontonoz P., Nelson M.C., Alvarez J.G., Ming U.T., Baird S.M., Thomazy V.A., and Evans R.M. Activators of the nuclear receptor PPAR γ enhance colon polyp formation. Nat. Med. 4 (1998) 1058-1061
23. Yang K., Fan K.H., Lamprecht S.A., Edelmann W., Kopelovich L., Kucherlapati R., and Lipkin M. Peroxisome proliferator-activated receptor gamma agonist troglitazone induces colon tumors in normal C57BL/6J mice and enhances colonic carcinogenesis in Apc(1638 N/+) Mlh1(+/-) double mutant mice. Int. J. Cancer 116 (2005) 495-499
24. Chintharlapalli S., Papineni S., Baek S.J., Liu S., and Safe S. 1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes are peroxisome proliferator-activated receptor γ agonists but decrease HCT-116 colon cancer cell survival through receptor-independent activation of early growth response-1 and NAG-1. Mol. Pharmacol. 68 (2005) 1782-1792
25. Chintharlapalli S., Papineni S., and Safe S. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPARγ-dependent and PPARγ-independent pathways. Mol. Cancer Ther. 5 (2006) 1362-1370
26. Lu J., Imamura K., Nomura S., Mafune K., Nakajima A., Kadowaki T., Kubota N., Terauchi Y., Ishii G., Ochiai A., Esumi H., and Kaminishi M. Chemopreventive effect of peroxisome proliferator-activated receptor gamma on gastric carcinogenesis in mice. Cancer Res. 65 (2005) 4769-4774
27. Chen Z.Y., and Tseng C.C. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells. Mol. Pharmacol. 68 (2005) 1203-1213
28. Okano H., Shiraki K., Inoue H., Kawakita T., Deguchi M., Sugimoto K., Sakai T., Murata K., Nakano T., and Enjoji M. The PPARγ ligand, 15-Deoxy-Delta12,14-PGJ2, regulates apoptosis-related protein expression in cholangio cell carcinoma cells. Int. J. Mol. Med. 12 (2003) 867-870
29. Rumi M.A., Ishihara S., Kadowaki Y., Ortega-Cava C.F., Kazumori H., Kawashima K., Yoshino N., Yuki T., Ishimura N., and Kinoshita Y. Peroxisome proliferator-activated receptor γ-dependent and -independent growth inhibition of gastrointestinal tumour cells. Genes Cells 9 (2004) 1113-1123
30. Okano H., Shiraki K., Inoue H., Yamanaka Y., Kawakita T., Saitou Y., Yamaguchi Y., Enokimura N., Yamamoto N., Sugimoto K., Murata K., and Nakano T. 15-Deoxy-delta-12-14-PGJ2 regulates apoptosis induction and nuclear factor-κB activation via a peroxisome proliferator-activated receptor-γ-independent mechanism in hepatocellular carcinoma. Lab. Invest. 83 (2003) 1529-1539
31. Bae M.A., Rhee H., and Song B.J. Troglitazone but not rosiglitazone induces G1 cell cycle arrest and apoptosis in human and rat hepatoma cell lines. Toxicol. Lett. 139 (2003) 67-75
32. Nikitakis N.G., Siavash H., Hebert C., Reynolds M.A., Hamburger A.W., and Sauk J.J. 15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells. Br. J. Cancer 87 (2002) 1396-1403
33. Dai Y., Qiao L., Chan K.W., Zou B., Ma J.., Lan H.Y., Gu Q., Li Z., Wang Y., Wong B.L.W., and Wong B.C.Y. Loss of XIAP sensitizes Rosiglitazone-induced growth inhibition of colon cancer in vivo. Int. J. Cancer 122 (2008) 2858-2863
34. Cummins J.M., Kohli M., Rago C., Kinzler K.W., Vogelstein B., and Bunz F. X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells. Cancer Res. 64 (2004) 3006-3008
35. Heideman D.A., van Beusechem V.W., Bloemena E., Snijders P.J., Craanen M.E., Offerhaus G.J., Derksen P.W., de Bruin M., Witlox M.A., Molenaar B., Meijer C.J., and Gerritsen W.R. Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4. J. Gene Med. 6 (2004) 317-327
36. Allred C.D., and Kilgore M.W. Selective activation of PPARγ in breast, colon, and lung cancer cell lines. Mol. Cell Endocrinol. 235 (2005) 21-29
37. Qiao L., Zhang H., Yu J., Francisco R., Dent P., Ebert M.P., Röcken C., and Farrell G. Constitutive activation of NF-κB in human hepatocellular carcinoma: evidence of a cytoprotective role. Hum. Gene Ther. 17 (2006) 280-290
38. Osawa E., Nakajima A., Wada K., Ishimine S., Fujisawa N., Kawamori T., Matsuhashi N., Kadowaki T., Ochiai M., Sekihara H., and Nakagama H. Peroxisome proliferator-activated receptor γ ligands suppress colon carcinogenesis induced by azoxymethane in mice. Gastroenterology 124 (2003) 361-367
39. Tanaka T., Kohno H., Yoshitani S., Takashima S., Okumura A., Murakami A., and Hosokawa M. Ligands for peroxisome proliferator-activated receptors α and γ inhibit chemically induced colitis and formation of aberrant crypt foci in rats. Cancer Res. 61 (2001) 2424-2428
40. Lee C.J., Han J.S., Seo C.Y., Park T.H., Kwon H.C., Jeong J.S., Kim I.H., Yun J., Bae Y.S., Kwak J.Y., and Park J.I. Pioglitazone, a synthetic ligand for PPARγ, induces apoptosis in RB-deficient human colorectal cancer cells. Apoptosis 11 (2006) 401-411
41. Grommes C., Landreth G.E., Sastre M., Beck M., Feinstein D.L., Jacobs A.H., Schlegel U., and Heneka M.T. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor γ agonist treatment. Mol. Pharmacol. 70 (2006) 1524-1533
42. Ngan C.Y., Yamamoto H., Seshimo I., Ezumi K., Terayama M., Hemmi H., Takemasa I., Ikeda M., Sekimoto M., and Monden M. A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer. J. Surg. Oncol. 95 (2007) 652-662
43. Kato M., Kusumi T., Tsuchida S., Tanaka M., Sasaki M., and Kudo H. Induction of differentiation and peroxisome proliferator-activated receptor γ expression in colon cancer cell lines by troglitazone. J. Cancer Res. Clin. Oncol. 130 (2004) 73-79